Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Customized Choice of P2Y12 Oral Receptor Blocker Based on Phenotype Assessment Via Point of Care Testing

NCT01477775 is registered in ClinicalTrials.gov with Italian Society of Invasive Cardiology as lead sponsor.

NCT NCT01477775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01477775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Customized Choice of P2Y12 Oral Receptor Blocker Based on Phenotype Assessment Via Point of Care Testing
Lead sponsor
Italian Society of Invasive Cardiology
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2012
Completion date
December 31, 2015
Enrollment
4,000 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, coronary angioplasty